adjuvant placebo

BIOLOGICAL2 trials

Sponsors

Changchun BCHT Biotechnology Co.

Conditions

HerpesInfluenza

Phase 1

A Phase I Trial to Evaluate the Safety and Immunogenicity of Influenza Virus Split Vaccine (Adjuvant)

Not yet recruitingNCT07349017

Changchun BCHT Biotechnology Co.Influenza

Start: 2026-02-07End: 2027-03-07Target: 160Updated: 2026-01-16

A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

Enrolling by invitationNCT07633197

Changchun BCHT Biotechnology Co.Herpes

Start: 2026-05-28End: 2027-11-30Target: 120Updated: 2026-06-08